SHILPAMED.NSSHILPAMED.NSNSE
Loading
Year-over-year revenue growth rate
Latest
10.75%
↑ 198% vs avg
Percentile
P67
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
3.61%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 10.75% |
| Q3 2025 | 15.09% |
| Q2 2025 | -2.82% |
| Q1 2025 | 3.59% |
| Q4 2024 | -7.12% |
| Q3 2024 | 17.53% |
| Q2 2024 | 0.45% |
| Q1 2024 | 1.65% |
| Q4 2023 | -8.47% |
| Q3 2023 | 20.29% |
| Q2 2023 | -1.28% |
| Q1 2023 | 0.40% |
| Q4 2022 | -0.16% |
| Q3 2022 | 0.67% |
| Q2 2022 | -23.32% |
| Q1 2022 | 25.08% |
| Q4 2021 | -7.78% |
| Q3 2021 | 24.40% |
| Q2 2021 | 14.60% |
| Q1 2021 | 8.30% |
| Q4 2020 | -31.44% |
| Q3 2020 | 25.16% |
| Q2 2020 | 1.31% |
| Q1 2020 | -7.12% |
| Q4 2019 | -18.30% |
| Q3 2019 | 80.08% |
| Q2 2019 | -19.42% |
| Q1 2019 | 15.20% |
| Q4 2018 | 6.87% |
| Q3 2018 | -18.11% |
| Q2 2018 | -15.48% |
| Q1 2018 | 26.38% |
| Q4 2017 | -9.05% |
| Q3 2017 | 23.03% |
| Q2 2017 | -25.17% |
| Q1 2017 | 21.80% |
| Q4 2016 | -13.23% |
| Q3 2016 | 26.27% |
| Q2 2016 | -15.38% |
| Q1 2016 | -1.01% |